1. Surrogate endpoints in clinical trials: definition and operational criteria;Prentice;Statistics in Medicine,1989
2. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework;Biomarkers Definitions Working Group;Clinical Pharmacology & Therapeutics,2001
3. Food and Drug Administration Code of Federal Regulations 21 314.50 and 601.40 US Department of Health and Human Services, Food and Drug Administration Rockville, MD